Low DMSO Cryopreservation of Stem Cells Enabled by Macromolecular Cryoprotectants

Kathryn A. Murray, Ruben M. F. Tomás, Matthew I. Gibson

Research output: Contribution to journalArticlepeer-review

10 Downloads (Pure)

Abstract

Mesenchymal stromal (stem) cells have potential in regenerative medicine and modulating the immune system. To deliver any cell-based therapy to the patient, it must be cryopreserved, most commonly in DMSO, which impacts cell function and causes clinical side effects. Here we report the use of a synthetically scalable polyampholyte to rescue the cryopreservation of mesenchymal stromal cells in low [DMSO] cryopreservation. Flow cytometry showed retention of key markers of multipotency comparable to 10% (v/v) DMSO, and the cells could be differentiated, showing this polymer material can be used to improve, or replace, current cryopreservation strategies.
Original languageEnglish
Pages (from-to)5627–5632
Number of pages6
JournalACS Applied Bio Materials
Volume3
Issue number9
Early online date18 Aug 2020
DOIs
Publication statusPublished - 21 Sept 2020

Keywords

  • cryopreservation
  • stem cells
  • polymers
  • polyampholyte
  • biomaterials

Fingerprint

Dive into the research topics of 'Low DMSO Cryopreservation of Stem Cells Enabled by Macromolecular Cryoprotectants'. Together they form a unique fingerprint.

Cite this